Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2026 10:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global In Vitro Diagnostics Market to Reach USD 157.63 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL , March 12, 2026 (GLOBE NEWSWIRE) -- The global in vitro diagnostics (IVD) market, valued at USD 101.05 billion in 2024, has advanced to USD 109.06 billion in 2025 and is projected...
March 12, 2026 10:00 ET | Source: Foundation for Opioid Response Efforts

FORE Awards $550,000 Grant to Expand Youth Substance Use Prevention Program on Pine Ridge Reservation

New York, March 12, 2026 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced a $550,000 two-year grant to Project Venture, an Indigenous-led nonprofit organization...
March 12, 2026 09:30 ET | Source: Curanex Pharmaceuticals Inc

Curanex Expands Scientific Advisory Board With Two Distinguished Researchers

New Appointments Bring Deep Expertise in Immunology and Infectious Disease to Advance IND Submission and Intellectual Property Strategy Jericho, New York, March 12, 2026 (GLOBE NEWSWIRE) -- Curanex...
March 12, 2026 09:00 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of NuScale Power Corporation Investors

LOS ANGELES, March 12, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises NuScale Power Corporation, (“NuScale” or the "Company") (NYSE: SMR) investors off a class action on behalf of investors...
March 11, 2026 09:07 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results

Vancouver, Canada, March 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and...
March 11, 2026 08:00 ET | Source: Biogen Inc.

Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy

New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene...
March 10, 2026 09:15 ET | Source: USA News Group

The Race for Uranium Has Gone Global

VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- USANewsgroup.com News Commentary — The United States currently imports roughly 95% of the uranium it consumes, leaving the world’s...
March 09, 2026 16:30 ET | Source: Mesa Laboratories, Inc.

Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO

LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and...
March 09, 2026 07:00 ET | Source: Relmada Therapeutics

Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer

Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR rate at 12 months and 94% CR rate at any time...
March 09, 2026 07:00 ET | Source: NRx Pharmaceuticals, Inc.

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

Published results have shown 87% clinical response to non-invasive Transcranial Magnetic Stimulation with neuroplastic medications.Clinical leadership by physicians trained at Harvard, Johns Hopkins,...